Sanjeev Raghuwanshi

Anthracycline and antimetabolite, trigger distinct resistance mechanisms in TP53mut AML

Acute myeloid leukemia (AML) is a highly heterogeneous and extremely aggressive form of blood cancer. Despite recent advances, AML continues to be a challenging disease to treat; the overall prognosis and response to therapy are strongly influenced by karyotypic and molecular alt...